Characterizing Fluorescence Emissions of Hairpin DNA-Templated Silver Nanoclusters by cDNA Hybridization
Stem-loop hairpin DNA probes have excessive hybridization specificity and distinctive selectivity to focus on molecules equivalent to DNA and small molecules. DNA-templated silver nanoclusters (DNA-AgNCs) has been extensively used to detect biomolecules of curiosity because of the photostable, brilliant, and environment friendly strategies. On this examine, we measured fluorescence emission of hairpin DNA upon hybridization with cDNA and mutant cDNA (cDNA-1) or mutant cDNA containing mismatched bases within the stem area (cDNA-2).
Fluorescence depth of hairpin DNA-AgNCs within the presence of cDNA was 1.80 instances greater than that of hairpin DNA-AgNCs alone, however decreased to 66% within the presence of cDNA-1 containing mismatched base similar to the hairpin stem area. This examine demonstrated that fluorescence intensities of hairpin DNA-AgNCs had been depending on hybridization with both wild-type and mutant cDNAs.
 Tissue, Total Protein, Human Disease, Liver Cirrhosis, Kidney |
|
MBS657247-1mg |
MyBiosource |
1mg |
EUR 820 |
Tissue, Total Protein, Human Disease, Liver Cirrhosis, Kidney |
|
MBS657247-5x1mg |
MyBiosource |
5x1mg |
EUR 3470 |
 Genomic DNA - Liver Cirrhosis: Kidney, from a single donor |
|
D1236142Lcs |
Biochain |
50 ug |
EUR 413 |
) Tissue, Section, Human Disease, Liver Cirrhosis, Kidney (Paraffin) |
|
MBS640354-5Sections |
MyBiosource |
5Sections |
EUR 510 |
Tissue, Section, Human Disease, Liver Cirrhosis, Kidney (Paraffin) |
|
MBS640354-5x5Sections |
MyBiosource |
5x5Sections |
EUR 2145 |
 cDNA - Liver Cirrhosis: Liver |
|
C1236149Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 Tissue, Total RNA, Human Disease, Liver Cirrhosis, Kidney, BioGenomics |
|
MBS638511-005mg |
MyBiosource |
0.05mg |
EUR 655 |
Tissue, Total RNA, Human Disease, Liver Cirrhosis, Kidney, BioGenomics |
|
MBS638511-5x005mg |
MyBiosource |
5x0.05mg |
EUR 2735 |
 Tissue, Genomic DNA, Human Disease, Liver Cirrhosis, Kidney, BioGenomics |
|
MBS654423-005mg |
MyBiosource |
0.05mg |
EUR 715 |
Tissue, Genomic DNA, Human Disease, Liver Cirrhosis, Kidney, BioGenomics |
|
MBS654423-5x005mg |
MyBiosource |
5x0.05mg |
EUR 3075 |
 cDNA - Liver Cirrhosis: Lung |
|
C1236152Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Skin |
|
C1236218Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Brain |
|
C1236035Lcs |
Biochain |
40 reactions |
EUR 600.6 |
 cDNA - Liver Cirrhosis: Colon |
|
C1236090Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Heart |
|
C1236122Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Spleen |
|
C1236246Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Pancreas |
|
C1236188Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Esophagus |
|
C1236106Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Diaphragm |
|
C1236169Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Lymph Node |
|
C1236161Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Spinal Cord |
|
C1236234Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Small Intestine |
|
C1236226Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Small Intestine: Ileum |
|
C1236227Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Small Intestine: Jejunum |
|
C1236230Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 cDNA - Liver Cirrhosis: Small Intestine: Duodenum |
|
C1236101Lcs |
Biochain |
40 reactions |
EUR 589.4 |
 Liver Liver Cirrhosis Lysate |
|
XBL-10358 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human liver tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Liver, BioGenomics |
|
MBS652035-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Liver, BioGenomics |
|
MBS652035-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Liver Membrane Liver Cirrhosis Lysate |
|
XBL-10671 |
ProSci |
0.1 mg |
EUR 752.1 |
|
Description: Human liver tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human liver tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated liver tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated liver tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
 Lung Liver Cirrhosis Lysate |
|
XBL-10363 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human lung tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Skin Liver Cirrhosis Lysate |
|
XBL-10376 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human skin tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human skin tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the skin tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The skin tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Brain Liver Cirrhosis Lysate |
|
XBL-10124 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human brain tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human brain tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the brain tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The brain tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Colon Liver Cirrhosis Lysate |
|
XBL-10334 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human colon tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human colon tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the colon tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The colon tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Heart Liver Cirrhosis Lysate |
|
XBL-10343 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human heart tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human heart tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the heart tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The heart tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Ileum Liver Cirrhosis Lysate |
|
XBL-10380 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human small intestine: Ileum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Ileum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Ileum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Ileum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Rectum Liver Cirrhosis Lysate |
|
XBL-10375 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human rectum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human rectum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the rectum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The rectum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Spleen Liver Cirrhosis Lysate |
|
XBL-10385 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human spleen tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human spleen tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the spleen tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The spleen tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Testis Liver Cirrhosis Lysate |
|
XBL-10389 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human testis tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human testis tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the testis tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The testis tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Adrenal Liver Cirrhosis Lysate |
|
XBL-10315 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human adrenal tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human adrenal tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the adrenal tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The adrenal tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Jejunum Liver Cirrhosis Lysate |
|
XBL-10382 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human small intestine: Jejunum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Jejunum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Jejunum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Jejunum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Thyroid Liver Cirrhosis Lysate |
|
XBL-10390 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human thyroid tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human thyroid tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the thyroid tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The thyroid tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Lung, BioGenomics |
|
MBS651928-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Lung, BioGenomics |
|
MBS651928-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Skin, BioGenomics |
|
MBS652450-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Skin, BioGenomics |
|
MBS652450-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Human Liver Cirrhosis Liver Tissue Lysate |
|
IHULRCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Liver Tissue Lysate |
Human Liver Cirrhosis Liver Tissue Lysate |
|
MBS8414653-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Liver Tissue Lysate |
|
MBS8414653-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
 Appendix Liver Cirrhosis Lysate |
|
XBL-10317 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human appendix tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human appendix tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the appendix tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The appendix tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Duodenum Liver Cirrhosis Lysate |
|
XBL-10337 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human duodenum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human duodenum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the duodenum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The duodenum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Pancreas Liver Cirrhosis Lysate |
|
XBL-10372 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human pancreas tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human pancreas tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the pancreas tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The pancreas tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Prostate Liver Cirrhosis Lysate |
|
XBL-10374 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human prostate tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human prostate tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the prostate tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The prostate tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Esophagus Liver Cirrhosis Lysate |
|
XBL-10339 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human esophagus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human esophagus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the esophagus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The esophagus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Diaphragm Liver Cirrhosis Lysate |
|
XBL-10368 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human diaphragm tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human diaphragm tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the diaphragm tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The diaphragm tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Spleen, BioGenomics |
|
MBS652239-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Spleen, BioGenomics |
|
MBS652239-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Colon, BioGenomics |
|
MBS652319-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Colon, BioGenomics |
|
MBS652319-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Brain, BioGenomics |
|
MBS652320-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Brain, BioGenomics |
|
MBS652320-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Heart, BioGenomics |
|
MBS652384-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Heart, BioGenomics |
|
MBS652384-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Gallbladder Liver Cirrhosis Lysate |
|
XBL-10340 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human gallbladder tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human gallbladder tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the gallbladder tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The gallbladder tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Duodenum, BioGenomics |
|
MBS651969-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Duodenum, BioGenomics |
|
MBS651969-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Pancreas, BioGenomics |
|
MBS652516-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Pancreas, BioGenomics |
|
MBS652516-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Diaphragm, BioGenomics |
|
MBS651903-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Diaphragm, BioGenomics |
|
MBS651903-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Esophagus, BioGenomics |
|
MBS652173-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Esophagus, BioGenomics |
|
MBS652173-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Lymph node Liver Cirrhosis Lysate |
|
XBL-10366 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human lymph node tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human lymph node tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lymph node tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lymph node tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Spinal cord Liver Cirrhosis Lysate |
|
XBL-10125 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human spinal cord tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human spinal cord tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the spinal cord tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The spinal cord tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Lymph node, BioGenomics |
|
MBS652040-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Lymph node, BioGenomics |
|
MBS652040-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Spinal cord, BioGenomics |
|
MBS652176-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Spinal cord, BioGenomics |
|
MBS652176-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Small Intestine Liver Cirrhosis Lysate |
|
XBL-10377 |
ProSci |
0.1 mg |
EUR 796.2 |
|
Description: Human small intestine tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Small intestine, BioGenomics |
|
MBS652026-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Small intestine, BioGenomics |
|
MBS652026-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
 Human Liver Cirrhosis Liver Lysate Membrane Fraction |
|
IHULRCIRTLM100UG |
Innovative research |
each |
EUR 1199 |
|
|
|
Description: Human Liver Cirrhosis Liver Lysate Membrane Fraction |
Human Liver Cirrhosis Liver Lysate Membrane Fraction |
|
MBS8414654-01mg |
MyBiosource |
0.1mg |
EUR 1550 |
Human Liver Cirrhosis Liver Lysate Membrane Fraction |
|
MBS8414654-5x01mg |
MyBiosource |
5x0.1mg |
EUR 6780 |
 OCPB00662-100UG - Liver Membrane Liver Cirrhosis Lysate |
|
OCPB00662-100UG |
Aviva Systems Biology |
0.1mg |
EUR 689 |
|
|
 Human Liver Cirrhosis Lung Tissue Lysate |
|
IHULGCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Lung Tissue Lysate |
 Human Liver Cirrhosis Skin Tissue Lysate |
|
IHUSKNCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Skin Tissue Lysate |
Human Liver Cirrhosis Skin Tissue Lysate |
|
MBS8419502-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Skin Tissue Lysate |
|
MBS8419502-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
Human Liver Cirrhosis Lung Tissue Lysate |
|
MBS8414459-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Lung Tissue Lysate |
|
MBS8414459-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
 Human Liver Cirrhosis Brain Tissue Lysate |
|
IHUBRCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Brain Tissue Lysate |
 Human Liver Cirrhosis Colon Tissue Lysate |
|
IHUCLNCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Colon Tissue Lysate |
Human Liver Cirrhosis Brain Tissue Lysate |
|
MBS138056-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Brain Tissue Lysate |
|
MBS138056-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
Human Liver Cirrhosis Colon Tissue Lysate |
|
MBS139593-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Colon Tissue Lysate |
|
MBS139593-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
 Human Liver Cirrhosis Heart Tissue Lysate |
|
IHUHTCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Heart Tissue Lysate |
 Human Liver Cirrhosis Ileum Tissue Lysate |
|
IHUILMCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Ileum Tissue Lysate |
Human Liver Cirrhosis Heart Tissue Lysate |
|
MBS8413247-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Heart Tissue Lysate |
|
MBS8413247-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
Human Liver Cirrhosis Ileum Tissue Lysate |
|
MBS8413585-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Ileum Tissue Lysate |
|
MBS8413585-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
 Tissue, Total Protein, Human Disease, Liver Cirrhosis, Liver |
|
MBS657558-1mg |
MyBiosource |
1mg |
EUR 820 |
Tissue, Total Protein, Human Disease, Liver Cirrhosis, Liver |
|
MBS657558-5x1mg |
MyBiosource |
5x1mg |
EUR 3470 |
 Genomic DNA - Liver Cirrhosis: Liver, from a single donor |
|
D1236149Lcs |
Biochain |
50 ug |
EUR 413 |
 Human Liver Cirrhosis Rectum Tissue Lysate |
|
IHURCTCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Rectum Tissue Lysate |
 Human Liver Cirrhosis Spleen Tissue Lysate |
|
IHUSPCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Spleen Tissue Lysate |
 Human Liver Cirrhosis Testis Tissue Lysate |
|
IHUTSTCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Testis Tissue Lysate |
Human Liver Cirrhosis Spleen Tissue Lysate |
|
MBS8420014-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Spleen Tissue Lysate |
|
MBS8420014-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
Human Liver Cirrhosis Testis Tissue Lysate |
|
MBS8420126-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Testis Tissue Lysate |
|
MBS8420126-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
Human Liver Cirrhosis Rectum Tissue Lysate |
|
MBS8418431-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Rectum Tissue Lysate |
|
MBS8418431-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
 Human Liver Cirrhosis Jejunum Tissue Lysate |
|
IHUJEJCIRTL100UG |
Innovative research |
each |
EUR 1413 |
|
|
|
Description: Human Liver Cirrhosis Jejunum Tissue Lysate |
Human Liver Cirrhosis Jejunum Tissue Lysate |
|
MBS8413807-01mg |
MyBiosource |
0.1mg |
EUR 1810 |
Human Liver Cirrhosis Jejunum Tissue Lysate |
|
MBS8413807-5x01mg |
MyBiosource |
5x0.1mg |
EUR 7965 |
 Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Small intestine, Ileum, BioGenomics |
|
MBS652396-40Tests |
MyBiosource |
40Tests |
EUR 995 |
Tissue cDNA, First Strand, Human Diseased, Liver Cirrhosis, Small intestine, Ileum, BioGenomics |
|
MBS652396-5x40Tests |
MyBiosource |
5x40Tests |
EUR 4250 |
Correction of X-CGD affected person HSPCs by focused CYBB cDNA insertion utilizing CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed restore
X-linked persistent granulomatous illness is an immunodeficiency characterised by faulty manufacturing of microbicidal reactive oxygen species (ROS) by phagocytes. Causative mutations happen all through the 13 exons and splice websites of the CYBB gene, leading to loss of gp91phox protein. Right here we report gene correction by homology-directed restore in affected person hematopoietic stem/progenitor cells (HSPCs) utilizing CRISPR/Cas9 for focused insertion of CYBB exon 1-13 or 2-13 cDNAs from adeno-associated virus donors at endogenous CYBB exon 1 or exon 2 websites. Focused insertion of exon 1-13 cDNA didn’t restore physiologic gp91phox ranges, in line with a requirement for intron 1 in CYBB expression. Nonetheless, insertion of exon 2-13 cDNA absolutely restored gp91phox and ROS manufacturing upon phagocyte differentiation. Addition of a woodchuck hepatitis virus post-transcriptional regulatory ingredient didn’t additional improve gp91phox expression in exon 2-13 corrected cells, indicating that retention of intron 1 was adequate for optimum CYBB expression.
Focused correction was elevated ~1.5-fold utilizing i53 mRNA to transiently inhibit nonhomologous finish becoming a member of. Following engraftment in NSG mice, corrected HSPCs generated phagocytes with restored gp91phox and ROS manufacturing. Our findings show the utility of tailoring donor design and focusing on methods to retain regulatory parts wanted for optimum expression of the goal gene.
doghealth1
Stem II-disrupting pseudoknot doesn’t abolish means of Senecavirus A IRES to provoke protein expression, however inhibits restoration of virus from cDNA clone
Senecavirus A (SVA) is classed into the genus Senecavirus within the household Picornaviridae. Its genome is a positive-sense, single-stranded and nonsegmented RNA, roughly 7300 nucleotides in size. A picornaviral genome is actually an mRNA, which, albeit unmodified with 5′ cap construction, can nonetheless provoke protein expression by the interior ribosome entry website (IRES). The SVA genome accommodates a hepatitis C virus-like IRES, through which a pseudoknot construction performs an vital function in initiating protein expression. On this examine, we constructed a set of SVA (CH-LX-01-2016 pressure) minigenomes with all mixtures of level mutations in its pseudoknot stem II (PKS-II).
The outcomes confirmed that any mixture of level mutations couldn’t considerably intrude with the IRES to provoke protein expression. Additional, we constructed a full-length SVA cDNA clone, through which the PKS-II-forming cDNA motif was subjected to site-directed mutagenesis for completely disrupting the PKS-II formation in IRES. Such a modified SVA cDNA clone was transfected into BSR-T7/5 cells, consequently demonstrating that the PKS-II-disrupting IRES interfered neither with protein expression nor with antigenome replication, whereas a reliable SVA couldn’t be rescued from the cDNA clone. It was speculated that the mutated motif probably disrupted a packaging sign for virion meeting, subsequently inflicting the failure of SVA rescue.
Development of an infectious full-length cDNA clone of potato aucuba mosaic virus
Potato aucuba mosaic virus (PAMV), a optimistic single-strand RNA virus, has one of many longest genomes of the viruses within the genus Potexvirus. In 2019, potato samples with mottle and crinkling signs from Huzhou, Zhejiang province, China, had been recognized to be contaminated with PAMV, potato virus X (PVX), and potato virus Y (PVY) by transcriptome sequencing.
To check the results of single an infection by PAMV, the full-length sequence of PAMV from Huzhou (MT193476) was decided and an infectious full-length cDNA clone was constructed. This cDNA clone was infectious by agro-infiltration, resulting in systemic signs in Nicotiana benthamiana, tomato, pepper, and potato.
Speedy Era of a Recombinant Genotype VIII Newcastle Illness Virus (NDV) Utilizing Full-Size Artificial cDNA
Rescue of (-)ssRNA viruses entails the sequential meeting and cloning of the full-length cDNA, which is usually a difficult and time-consuming course of. The target of this examine was to develop a novel methodology to quickly clone the full-length cDNA of a really virulent NDV by just one meeting step. A totally artificial 15 kb cDNA of a Malaysian genotype VIII NDV generally known as pressure AF2240-I with further flanking BsmBI websites was synthesised. Nonetheless, to utterly comply with the rule-of-six, the extra G residues which are historically added after the T7 promoter transcription initiation website weren’t synthesised. The artificial fragment was then cloned into low-copy quantity transcription vector pOLTV5-phiX between the T7 promoter and HDV Rz sequences by digestion with BbsI. The assemble was co-transfected with helper plasmids into BSRT7/5 cells.
A recombinant NDV referred to as rAF was efficiently rescued utilizing transfection supernatant harvested as early as 16 h post-transfection. Virus from every passage confirmed an intracerebral pathogenicity index (ICPI) and a imply demise time (MDT) much like the mum or dad pressure AF2240-I. Furthermore, rAF possessed an launched mutation which was maintained for a number of passages. Your entire rescue utilizing the one-step meeting process was accomplished inside a couple of weeks, which is extraordinarily quick in comparison with beforehand used strategies.
Gene Expression Profiling of 2-(4-Aminophenyl)benzothiazole-resistant MCF-7 Cells Utilizing cDNA Microarrays.
CJM126, 2-(4-aminophenyl) benzothiazole, is a potent inhibitor of human-derived breast carcinoma cell traces. Earlier research have proven that CJM126 elicits concentration-dependent, biphasic development inhibitory results in opposition to a panel of estrogen receptor-positive and receptor-negative human mammary carcinoma cell traces by a mechanism which has not been absolutely elucidated.
MATERIALS AND METHODS
In an effort to know the mechanism(s) of resistance to CJM126, the current examine used cDNA microarrays (Clontech Laboratories, Inc.) representing 1,176 human cancer-related genes to research expression profile adjustments of two CJM126-resistant cell traces, MCF-710nM126 and MCF-710μM126, beforehand created by exposing MCF-7 cells to 10 nM and 10 μM CJM126, respectively.
RESULTS
Expression adjustments within the CJM126-resistant MCF-7 cell traces had been noticed in genes concerned in a wide range of cell signaling pathways. Gene expression adjustments widespread to MCF-710nM126 and MCF-710μM126 cells, as in comparison with delicate MCF-7wt cells, had been the shut-down of transcription issue Oct-2 and the up-regulation of the destructive apoptosis regulator MCL-1, the G1-to-S-phase regulator ubiquitin provider protein and the GTP-binding protein GST1-HS.
These findings point out the affiliation of a CJM126-resistance phenotype with profound gene transcription dysregulation, decreased apoptotic exercise and elevated proliferation. Particular adjustments distinctive to every of the CJM126-resistant cell traces had been additionally noticed. Genes concerned within the DNA mismatch-repair pathway, equivalent to MSH2, DNA restore protein RAD51 and damage-specific DNA binding protein had been down-regulated in MCF-710nM126, whereas genes concerned within the nucleotide-excision restore pathway, equivalent to ERCC1, RFC and PCNA had been overexpressed in MCF-710μM126
Conclusion: The differential adjustments within the DNA-repair pathways between MCF-710nM126 and MCF-710μM126 cell traces point out that completely different processes might have been employed to avoid the expansion inhibition produced by publicity to CJM126. This may additionally counsel that CJM126 might have concentration-dependent mechanisms of development inhibition.
